Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0010033
|
response to organic substance |
CCND1,SRF,BCL2,BRCA2,BCL2L1,SLC9A1,AACS,CD83,DNAJB1,NOD2,ACVR1C,SOCS1,PRKRA,CREB1,TRIB1,A2M,IGF1R,HMOX1,ADAM17,PFKFB2,PTPN1,GSTM3,ADAM10,ARSB, |
1.11E-4 |
GO:0042127
|
regulation of cell proliferation |
SOX2,B4GALT1,PRKRA,FOXP1,TRIB1,CLEC11A,TBX19,PMP22,IGF1R,ADAM17,TPD52L2,ADAM10,CALR,CCND1,BRCA2,BCL2,BCL2L1,BAX,VHL,CDK4,TOB2,HMOX1,PPP1R9B,NODAL,EGLN3, |
1.56E-4 |
GO:0051270
|
regulation of cell motion |
IGF1R,HMOX1,ADAM17,BCL2,CLIC4,B4GALT1,CHST3,TRIB1,ADAM10,RAC1,SPAG9, |
2.96E-4 |
GO:0007015
|
actin filament organization |
BCL2,RHOA,CALD1,ALDOA,PPP1R9B,WASF1,RAC1, |
4.20E-4 |
GO:0009628
|
response to abiotic stimulus |
CCND1,SOX2,NLGN3,CASP7,BCL2,BRCA2,BCL2L1,SLC9A1,BAX,KRT14,ANXA7,ATP1A2,GTF2H2,RAC1,ARSB, |
4.83E-4 |
|
GO:0008361
|
regulation of cell size |
MTPN,ADAM17,BCL2,SLC9A1,NDRG4,PPP1R9B,CDK4,CREB1,NDRG3,ADAM10,CCNG1, |
5.00E-4 |
GO:0032535
|
regulation of cellular component size |
MTPN,ADAM17,BCL2,SLC9A1,NDRG4,PPP1R9B,CDK4,CREB1,NDRG3,ADAM10,CCNG1,RAC1, |
1.15E-2 |
GO:0009411
|
response to UV |
CCND1,GTF2H2,BCL2,CASP7,BRCA2,BAX, |
1.18E-2 |
GO:0009719
|
response to endogenous stimulus |
CCND1,SRF,BCL2,BRCA2,BCL2L1,AACS,SOCS1,ACVR1C,A2M,IGF1R,HMOX1,ADAM17,PTPN1,GSTM3,ARSB, |
1.22E-2 |
GO:0014070
|
response to organic cyclic substance |
CCND1,HMOX1,BCL2,BRCA2,BCL2L1,SLC9A1,AACS,CD83, |
1.27E-2 |
GO:0021536
|
diencephalon development |
SOX2,WNT1,BAX,CREB1,TBX19, |
1.51E-2 |
GO:0009314
|
response to radiation |
CCND1,GTF2H2,NLGN3,BCL2,CASP7,BRCA2,BCL2L1,BAX,KRT14,ATP1A2, |
1.60E-2 |
GO:0046546
|
development of primary male sexual characteristics |
SOX2,CCND1,BCL2,BCL2L2,BCL2L1,BAX, |
1.83E-2 |
GO:0010038
|
response to metal ion |
CCND1,SLC11A2,BCL2,BCL2L1,ATP7A,KRT14,NDRG1,ANXA11, |
1.84E-2 |
GO:0010035
|
response to inorganic substance |
CCND1,A2M,SLC11A2,HMOX1,BCL2,BCL2L1,ATP7A,KRT14,NDRG1,ANXA11, |
1.90E-2 |
GO:0030334
|
regulation of cell migration |
IGF1R,HMOX1,ADAM17,BCL2,CLIC4,TRIB1,ADAM10,RAC1,SPAG9, |
2.11E-2 |
GO:0042493
|
response to drug |
CCND1,ADAM17,BCL2,SLC9A1,CTPS,AACS,SLC15A2,SOCS1,CENPF,CREB1, |
2.70E-2 |
GO:0009416
|
response to light stimulus |
CCND1,GTF2H2,NLGN3,BCL2,CASP7,BRCA2,BAX,ATP1A2, |
2.70E-2 |
GO:0001836
|
release of cytochrome c from mitochondria |
BCL2,CASP7,BCL2L1,BAX, |
2.70E-2 |
GO:0042981
|
regulation of apoptosis |
CALR,BCL2,BRCA2,BCL2L2,BCL2L1,BAX,B4GALT1,KRT18,VHL,NOD2,ACVR1C,CREB1,PRKRA,PEA15,SLC11A2,IGF1R,HMOX1,ADAM17,RHOA,ATP7A,PLAGL2,RAC1, |
2.87E-2 |
GO:0007584
|
response to nutrient |
SOX2,CCND1,A2M,HMOX1,BCL2,BRCA2,AACS,ARSB, |
2.93E-2 |
GO:0043627
|
response to estrogen stimulus |
CCND1,HMOX1,BCL2,BRCA2,GSTM3,SOCS1,ARSB, |
3.00E-2 |
GO:0046661
|
male sex differentiation |
SOX2,CCND1,BCL2,BCL2L2,BCL2L1,BAX, |
3.06E-2 |
GO:0043067
|
regulation of programmed cell death |
CALR,BCL2,BRCA2,BCL2L2,BCL2L1,BAX,B4GALT1,KRT18,VHL,NOD2,ACVR1C,CREB1,PRKRA,PEA15,SLC11A2,IGF1R,HMOX1,ADAM17,RHOA,ATP7A,PLAGL2,RAC1, |
3.22E-2 |
GO:0005996
|
monosaccharide metabolic process |
BPGM,PFKFB2,PHKA1,ALDOA,G6PC3,B4GALT1,PKM2,GNPDA2,GYS1,POFUT1, |
3.24E-2 |
GO:0010941
|
regulation of cell death |
CALR,BCL2,BRCA2,BCL2L2,BCL2L1,BAX,B4GALT1,KRT18,VHL,NOD2,ACVR1C,CREB1,PRKRA,PEA15,SLC11A2,IGF1R,HMOX1,ADAM17,RHOA,ATP7A,PLAGL2,RAC1, |
3.36E-2 |
GO:0009725
|
response to hormone stimulus |
CCND1,SRF,BCL2,BRCA2,BCL2L1,SOCS1,ACVR1C,IGF1R,A2M,HMOX1,PTPN1,GSTM3,ARSB, |
4.25E-2 |
GO:0042325
|
regulation of phosphorylation |
CCND1,BCL2,BAX,PAK1,NOD2,SOCS1,TRIB1,DUSP2,ADAM17,PFKFB2,PPP1R9B,ATP7A,CCNG1,RAC1,SPAG9, |
4.41E-2 |
GO:0007548
|
sex differentiation |
SOX2,CCND1,BCL2,BRCA2,BCL2L2,BCL2L1,BAX,B4GALT1, |
4.45E-2 |
GO:0040012
|
regulation of locomotion |
IGF1R,HMOX1,ADAM17,BCL2,CLIC4,TRIB1,ADAM10,RAC1,SPAG9, |
4.61E-2 |
GO:0019318
|
hexose metabolic process |
BPGM,PFKFB2,PHKA1,ALDOA,G6PC3,B4GALT1,PKM2,GYS1,POFUT1, |
4.61E-2 |
GO:0030900
|
forebrain development |
SOX2,WNT1,NUMBL,BAX,ATP7A,CREB1,RAC1,TBX19, |
4.61E-2 |
GO:0008584
|
male gonad development |
CCND1,BCL2,BCL2L2,BCL2L1,BAX, |
5.29E-2 |
GO:0019220
|
regulation of phosphate metabolic process |
CCND1,BCL2,BAX,PAK1,NOD2,SOCS1,TRIB1,DUSP2,ADAM17,PFKFB2,PPP1R9B,ATP7A,CCNG1,RAC1,SPAG9, |
6.22E-2 |
GO:0051174
|
regulation of phosphorus metabolic process |
CCND1,BCL2,BAX,PAK1,NOD2,SOCS1,TRIB1,DUSP2,ADAM17,PFKFB2,PPP1R9B,ATP7A,CCNG1,RAC1,SPAG9, |
6.22E-2 |
GO:0007010
|
cytoskeleton organization |
CALR,BCL2,BRCA2,ALDOA,CALD1,WASF1,PAK1,KRT14,DYNC1H1,ABLIM1,RHOA,PPP1R9B,RAC1,CNN3, |
6.38E-2 |
GO:0006916
|
anti-apoptosis |
IGF1R,HMOX1,ADAM17,BCL2,BCL2L2,BCL2L1,BAX,VHL,PEA15, |
7.06E-2 |
GO:0045137
|
development of primary sexual characteristics |
SOX2,CCND1,BCL2,BRCA2,BCL2L2,BCL2L1,BAX, |
7.57E-2 |
GO:0032989
|
cellular component morphogenesis |
BCL2,WNT1,NUMBL,BAX,VHL,CREB1,PMP22,IGF1R,RHOA,ATP7A,CHST3,NODAL,RAC1, |
7.81E-2 |
GO:0008637
|
apoptotic mitochondrial changes |
BCL2,CASP7,BCL2L1,BAX, |
8.28E-2 |
GO:0010212
|
response to ionizing radiation |
CCND1,BCL2,BRCA2,BAX,KRT14, |
8.76E-2 |
GO:0001932
|
regulation of protein amino acid phosphorylation |
CCND1,ADAM17,BCL2,BAX,PPP1R9B,NOD2,PAK1,SOCS1, |
9.18E-2 |
GO:0051881
|
regulation of mitochondrial membrane potential |
BCL2,BCL2L1,BAX, |
9.23E-2 |
GO:0046902
|
regulation of mitochondrial membrane permeability |
BCL2,BCL2L1,BAX, |
9.23E-2 |
GO:0016049
|
cell growth |
MTPN,BCL2,SLC9A1,NDRG4,CCNG1, |
9.28E-2 |
GO:0009636
|
response to toxin |
SRF,BCL2,BAX,ATP7A,SLC7A11, |
9.28E-2 |
GO:0001666
|
response to hypoxia |
SLC11A2,HMOX1,ADAM17,BCL2,BCL2L1,VHL,EGLN3, |
9.73E-2 |
GO:0050801
|
ion homeostasis |
CALR,NLGN3,BCL2,BCL2L1,SLC9A1,BAX,MT4,ANXA7,ATP1A2,PMP22,SLC11A2,HMOX1,ATP7A, |
9.76E-2 |
GO:0048732
|
gland development |
SOX2,IGF1R,BCL2,BRCA2,B4GALT1,CREB1,TBX19, |
1.00E-1 |
|
|
|
|
|
|